Indo Us Bio-Tech Valuation

Is 541304 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 541304 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 541304's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 541304's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 541304?

Key metric: As 541304 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 541304. This is calculated by dividing 541304's market cap by their current earnings.
What is 541304's PE Ratio?
PE Ratio	43.2x
Earnings	₹117.37m
Market Cap	₹5.07b

541304 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	6.1x
Enterprise Value/EBITDA	36.3x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does 541304's PE Ratio compare to its peers?

The above table shows the PE ratio for 541304 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	19.8x
KRISHIVAL Krishival Foods	44x	n/a	₹5.7b
MGEL Mangalam Global Enterprise	12.1x	n/a	₹3.2b
524542 Sukhjit Starch & Chemicals	15x	n/a	₹8.2b
NATHBIOGEN Nath Bio-Genes (India)	8.3x	n/a	₹3.3b
541304 Indo Us Bio-Tech	43.2x	n/a	₹5.1b

Price-To-Earnings vs Peers: 541304 is expensive based on its Price-To-Earnings Ratio (43.2x) compared to the peer average (19.8x).

Price to Earnings Ratio vs Industry

How does 541304's PE Ratio compare vs other companies in the IN Food Industry?

10 Companies	Price / Earnings	Estimated Growth	Market Cap
539594 Mishtann Foods	4.1x	n/a	US$177.02m
ZUARIIND Zuari Industries	1.2x	n/a	US$109.81m
SARVESHWAR Sarveshwar Foods	3.1x	n/a	US$101.71m
507315 Sakthi Sugars	4.4x	n/a	US$43.51m

10 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: 541304 is expensive based on its Price-To-Earnings Ratio (43.2x) compared to the Indian Food industry average (24.3x).

Price to Earnings Ratio vs Fair Ratio

What is 541304's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

541304 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	43.2x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 541304's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Bombay Burmah Trading Corporation

₹174.1b

Engages in the tea and coffee plantations, auto electric components, healthcare, and real estate businesses in India and internationally.

501425

₹2,495.65

-2.6%

74.0%

Bajaj Hindusthan Sugar

₹37.4b

Manufactures and sells sugar and alcohol in India.

BAJAJHIND

₹30.05

-2.8%

-8.9%

Gayatri Sugars

₹1.1b

Engages in the manufacture and sale of sugar and allied products in India.

532183

₹16.11

-2.1%

-35.3%